#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15030	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2289	654.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1543	1543	C	894	C,A	836,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15030	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2289	654.5	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1771	1771	T	882	TGGGGG,TGGGGGG	422,369	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15030	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2289	654.5	0	HET	.	.	.	A821G	.	821	821	A	1180	1180	A	903	A,G	626,218	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15030	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2289	654.5	0	HET	.	.	.	C1525T	.	1525	1525	C	1884	1884	C	756	C,T	362,332	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3499	795.2	0	.	n	.	0	T695C	SNP	695	695	T	1034	1034	C	886	C	834	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3499	795.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1977	1977	G	891	G,T,A	840,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3499	795.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2310	2310	C	910	C	854	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3499	795.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2384	2384	A	867	A	825	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3499	795.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2936	2936	C	860	C	793	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27918	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3499	795.2	0	HET	.	.	.	G324A	.	324	324	G	663	663	G	912	G,A	627,219	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2074	folP	855	855	100.0	folP.l15.c17.ctg.1	1419	145.4	1	SNP	p	R229S	1	.	.	685	687	AGC	964	966	AGC	189;190;190	A;G;C	182;184;183	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5616	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	165.4	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	184;184;182	T;T;C	172;170;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5616	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	165.4	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	184;185;187	G;G;C	170;170;174	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5616	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3385	165.4	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	184;185;187	G;G;C	170;170;174	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1766	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1307	134.7	0	.	p	.	0	F184L	NONSYN	550	552	TTC	830	832	TTG	220;216;213	T;T;G,C	209;204;201,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1766	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1307	134.7	1	SNP	p	G45D	0	.	.	133	135	GGC	413	415	GGC	243;242;239	G;G;C	229;224;224	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	838	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	961	86.3	0	.	n	.	0	A197.	DEL	197	197	A	560	560	A	193	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5570	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	186.8	1	SNP	p	D86N	0	.	.	256	258	GAC	614	616	GAC	214;213;213	G;A;C	197;198;200	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5570	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	186.8	1	SNP	p	R87W	0	.	.	259	261	CGT	617	619	CGT	213;214;215	C,A;G;T	199,1;199;195	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5570	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	186.8	1	SNP	p	R87I	0	.	.	259	261	CGT	617	619	CGT	213;214;215	C,A;G;T	199,1;199;195	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5570	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	186.8	1	SNP	p	S87R	1	.	.	259	261	CGT	617	619	CGT	213;214;215	C,A;G;T	199,1;199;195	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5570	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	186.8	1	SNP	p	S88P	0	.	.	262	264	TCC	620	622	TCC	216;219;220	T;C;C	200;206;206	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4460	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2485	178.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1475	1477	GGC	208;204;200	G;G;C	194;192;185	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1310	1312	GCA	214;209;211	G;C;A	196;194;197	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1313	1315	ATC	213;212;213	A;T;C	195;195;195	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1325	1327	GTG	215;213;213	G;T;G	197;190;191	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1325	1327	GTG	215;213;213	G;T;G	197;190;191	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1829	1831	ACC	180;179;181	A;C;C	169;171;173	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1883	1885	GCG	189;190;191	G;C,G;G	163;142,1;149	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1883	1885	GCG	189;190;191	G;C,G;G	163;142,1;149	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2006	2008	GGC	166;164;169	G;G;C	151;150;154	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2015	2017	GGC	165;164;161	G;G;C	149;144;146	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4082	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2369	171.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2033	2035	CCG	158;160;155	C,G;C;G	117,4;117;111	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5924	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3063	192.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1630	1632	CCG	206;205;206	C;C;G	176;187;182	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2332	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1964	118.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	612	612	C	166	C	149	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	348	350	GAA	224;221;222	G;A;A	208;206;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	0	.	p	.	0	K120N	NONSYN	358	360	AAG	594	596	AAT	233;235;234	A;A;T	219;221;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	636	638	GAT	238;240;243	G;A;T	226;229;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	759	761	TCA	242;239;244	T;C;A	225;225;230	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	0	.	p	.	0	A218I	NONSYN	652	654	GCC	888	890	ATC	227;230;230	A;T;C	213;212;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	900	902	TCT	244;245;244	T;C;T	226;230;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	1	SNP	p	A121D	1	.	.	361	363	GAC	597	599	GAC	229;227;229	G;A;C	214;213;216	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2888	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1424	201.2	1	SNP	p	D121N	0	.	.	361	363	GAC	597	599	GAC	229;227;229	G;A;C	214;213;216	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10862	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4990	217.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1128	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1050	106.9	1	SNP	p	V57M	1	.	.	169	171	ATG	490	492	ATG	251;255;252	A;T,A;G,A	231;233,1;232,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
